– Showcases AllplexTM HPV merchandise designed to check for 14 high-risk HPV genotypes
– Advocates HPV testing for early prognosis and prevention of cervical most cancers
– Goals to speed up the widespread adoption of syndromic PCR testing to create “a world free from all ailments”
Seegene reveals its sales space and demonstrates the HPV diagnostic merchandise with STARlet-AIOS™ at AOGIN 2024 on Thursday, July 11-13, 2024
SEOUL, July 16, 2024 – Seegene Inc. (KQ096530), a number one South Korean firm offering a complete answer for PCR molecular diagnostics, demonstrated its human papillomavirus (HPV) diagnostic merchandise and underscored the important significance of HPV screening take a look at on the Asia-Oceania Analysis Group in Genital An infection and Neoplasia (AOGIN) convention, held in Seoul, South Korea from July 11-13.
On the AOGIN, Seegene introduced its superior applied sciences for figuring out viruses linked to cervical most cancers. The corporate organized an exhibition sales space and hosted a symposium session underneath the theme of ‘Navigating medical tips and implementations for HPV cervical most cancers screening.’
The corporate showcased its distinctive quantitative PCR technology-based HPV diagnostic merchandise, ‘Allplex™ HPV HR Detection’ and ‘Allplex™ HPV28 Detection’. The Allplex™ HPV HR Detection is designed to check for 14 high-risk HPVs, together with sorts 16 and 18, in a single tube. The Allplex™ HPV28 Detection is designed to check for 28 HPVs, in two tubes, together with 19 high-risk sorts and 9 low-risk sorts, in two tubes. The merchandise are perfect for cervical most cancers prevention and follow-up administration.
The corporate additionally launched Seegene’s STARlet-AIOS™, a completely automated molecular diagnostic testing system that streamlines your complete PCR course of from nucleic acid extraction to end result evaluation, together with SG STATS, the corporate’s premium platform of superior statistical evaluation.
On the symposium session hosted by Seegene on July 11, Dr. Lan Xu from the Shanghai Jiao Tong College of Public Well being in China introduced a lecture on “Medical validation of human papillomavirus assays for cervical most cancers screening through the VALGENT framework.” Dr. Shin-Wha Lee from the Asan Medical Heart and College of Ulsan in Korea confirmed her examine on “Incorporating HPV testing with genotypes in population-based screening applications.”
“At AOGIN, we had been capable of showcase the excellence of Seegene’s PCR testing know-how and HPV merchandise. We count on our HPV merchandise to be adopted in cervical most cancers screening applications in additional nations,” mentioned Daniel Shin, Govt Vice-President and Chief World Gross sales and Advertising Officer at Seegene. “We’re at the moment working a marketing campaign within the world market to lift consciousness about the advantages of syndromic PCR testing, together with simultaneous testing for HPV and sexually transmitted infections (STIs). We imagine the marketing campaign will pave the way in which for the widespread adoption of syndromic PCR testing, serving to to appreciate “a world free from all ailments.”
Seegene’s syndromic quantitative PCR know-how is simultaneous multiplex molecular diagnostic know-how primarily based on real-time PCR. It permits for the detection of assorted pathogens inflicting comparable signs in a single tube, facilitating quick and correct prognosis. Moreover, analyzing the cycle threshold (Ct) worth helps decide the extent of the an infection, which boosts medical observe. Seegene is the primary to globally commercialize ‘3 Ct’ know-how, which might present the Ct worth of three targets in a single channel.
Cervical most cancers is the fourth commonest most cancers amongst ladies worldwide, with the second-highest mortality fee. In response to the World Well being Group (WHO), roughly 600,000 ladies are newly recognized with cervical most cancers every year globally, leading to 340,000 deaths. Within the Asia-Pacific area alone, about 270,000 ladies are recognized yearly, with over 140,000 deaths reported. The WHO has set a goal to attain 70% cervical most cancers screening protection by 2030, a major enhance from the present 20%. In 2020, solely 33% of ladies had been screened for cervical most cancers a minimum of as soon as.
There are about 200 HPV genotypes, of which 99.8% of cervical cancers are attributable to HPV. Sorts 16 and 18 account for 70% of cervical most cancers, whereas 19 high-risk sorts are chargeable for 90% of all most cancers instances. The development to most cancers depends upon the genotype of the HPV an infection, the extent of the an infection and co-infection. Since most HPV infections don’t current clear signs, correct detection is important for the early prognosis of cervical most cancers. Lately, many nations have been recommending HPV testing as a substitute of the Pap smear for cervical most cancers screening.
###
About Seegene
Seegene has 23 years of devoted R&D, manufacturing, and enterprise expertise round syndromic quantitative PCR applied sciences, which was highlighted throughout the COVID-19 pandemic when it offered over 340 million COVID-19 checks to greater than 100 nations worldwide. The core characteristic of Seegene’s distinctive syndromic PCR applied sciences is the flexibility to concurrently take a look at 14 pathogens that trigger comparable signs in a single tube and supply quantitative data on the infectivity profile to correlate with the severity of sickness.
About AOGIN 2024
The AOGIN, based in 2004, contains of 25 member nations in Asia and Oceania. The group hosts worldwide educational conferences centered on the remedy and prevention of cervical most cancers. This 12 months’s convention in Seoul attracted over 500 consultants from 22 nations, together with China, Japan, and India, who shared the most recent analysis findings and medical practices concerning HPV.
